|
Volumn 57, Issue 6, 2002, Pages 837-845
|
Role of FDG-PET scan in staging of cancer of the, esophagus and gastroesophageal junction
a a |
Author keywords
Esophageal neoplasms, diagnosis; Esophageal neoplasms, radionuclide imaging; Fludeoxyglucose; Stomach neoplasms, diagnosis; Stomach neoplasms, radionuclide imaging; Tomography, emission computed
|
Indexed keywords
ANTINEOPLASTIC AGENT;
FLUORODEOXYGLUCOSE;
ACCURACY;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER STAGING;
CANCER SURVIVAL;
CONTROLLED STUDY;
CORRELATION ANALYSIS;
COST BENEFIT ANALYSIS;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC IMAGING;
DIAGNOSTIC VALUE;
ESOPHAGUS;
ESOPHAGUS CARCINOMA;
HUMAN;
LOWER ESOPHAGUS SPHINCTER;
LYMPH NODE;
MAJOR CLINICAL STUDY;
METASTASIS;
POSITRON EMISSION TOMOGRAPHY;
STOMACH CARCINOMA;
TREATMENT OUTCOME;
ESOPHAGEAL NEOPLASMS;
ESOPHAGOGASTRIC JUNCTION;
FLUORODEOXYGLUCOSE F18;
HUMANS;
NEOPLASM STAGING;
PROSPECTIVE STUDIES;
RADIOPHARMACEUTICALS;
SENSITIVITY AND SPECIFICITY;
TOMOGRAPHY, EMISSION-COMPUTED;
|
EID: 0036926946
PISSN: 00264733
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (4)
|